Press releases
Stay informed about the latest developments and official statements in the cannabis industry with Business of Cannabis' collection of press releases. Learn about new products, industry news and more from top companies.
Press releases · page 24
- Press releases
Curaleaf International Announces Landmark Registration of Proprietary Range of Cannabis Products in Malta
CURALEAF International (the “Company”) part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce the successful license of the Company’s range of cannabis based medicines as extract, under the name Adven, in Malta.
- Press releases
Cheerful Buddha CBD Products First Of Their Kind Stocked In Major Retailers – Achieve Landmark FSA Listing
CHEERFUL Buddha is the first CBD coffee & CBD Chocolate brand stocked in major retailers – including Holland & Barrett & WHSmith Travel – to make the UK Food Standards Agency CBD Novel Food Public List.
- Press releases
Cellular Goods Announces First Patent Application For Skin Brightening Innovation
CELLULAR Goods (LSE: CBX), a UK-based wellness company that provides premium consumer products formulated with lab-made cannabinoids, is pleased to announce the filing of its first patent application related to the use of cannabinoids for skin brightening.
- Press releases
Update: Almost 2500 Additional CBD Products Added To The Public List
ALMOST 2,500 new CBD products have been added to the Food Standards Agency’s (FSA) public list this week.
- Press releases
Former Clinton Advisor Joins FoliuMed Advisory Board
FOLIUMED, a medical cannabis company with manufacturing and R&D in Germany and cultivation in South America, is pleased to announce the appointment of Howard M.
- Pharmaceutical
Oxford Cannabinoid Technologies Announces Formation of Scientific Advisory Board to Support Clinical Strategy
OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion pain market is pleased to announce the formation of its Scientific Advisory Board (“SAB”).
- Press releases
SynBiotic SE & Enchilada Group: Joint Venture To Launch First Cannabis Store In Germany
WHAT will the sale of cannabis products for recreational use look like in Germany?
- Press releases
MGC Pharma Patent Application For CimetrA Approved By European IP Office
MGC PHARMACEUTICALS Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development of phytomedicines, is pleased to announce the grant of a Patent for the Company’s Investigational Medical Product, CimetrATM, from the Slovenian Intellectual Property Office (SIPO).
- Press releases
Akanda To Acquire Portugal-Based Holigen, Securing A Cannabis Sector Leadership Position In Europe, The Middle East & Africa (EMEA) With EU GMP Market Access
INTERNATIONAL medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has entered into a definitive agreement to acquire 100% of the issued and outstanding shares of Holigen Limited (“Holigen”) from The Flowr Corporation (“Flowr”) (TSXV: FLWR, OTC: FLWPF).
- Press releases
Demecan Delivers First Medical Cannabis From Its Own German Facility
DEMECAN, the only independent German producer of medical cannabis, has made the first cannabis flowers available for collection by the German Federal Institute for Drugs and Medical Devices (BfArM).
- Press releases
66% of Americans Would Purchase Cannabis in Germany, According to New Report
THE “green rush” in Europe has commenced, and Americans are ready to invest their time, travel plans and money into the cannabis market across the pond, according to a new study.
- Press releases
New Poll Shows European Market Is Ready For Legal Recreational Cannabis
CURALEAF International (the “Company”), Europe’s largest vertically integrated cannabis company, welcomes the findings from a new European poll and report on the European recreational cannabis market, the first of its kind by Hanway Associates, an advisory firm specialising in strategy, research and M&A in the cannabis sector.
